Eris Lifesciences (ERIS.BO) Earnings Analysis

Eris Lifesciences (ERIS.BO) has no confirmed upcoming earnings date. Last quarter (2026-05-20) it beat with EPS 9.55 INR vs 9.43 INR est (+1.3%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E 30.87.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ERIS.BO next report earnings?

No confirmed upcoming earnings date is currently scheduled for ERIS.BO. This page updates as the calendar is published.

ERIS.BO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-209.55 INR9.43 INR+1.3%Beat
2026-02-138.3 INR9.63 INR-13.8%Miss
2025-05-196.89 INR6.6 INR+4.4%Beat
2024-10-256.72 INR7 INR-4%Miss
2024-08-026.1 INR6.4 INR-4.7%Miss

Beat rate: 2/5 (40%) over reported quarters with consensus data.

ERIS.BO valuation and analyst view

Trailing P/E30.87
Trailing EPS45.318 INR
Price / book4.91
Dividend yield0.51%
Market cap199.73B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Eris Lifesciences (ERIS.BO)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for ERIS.BO. This page updates as the calendar is published.

Did ERIS.BO beat earnings last quarter?

In its 2026-05-20 report, ERIS.BO posted EPS of 9.55 INR versus a 9.43 INR estimate — a beat of 1.3%.

What is ERIS.BO's earnings track record?

Over the last 5 reported quarters with consensus data, ERIS.BO beat estimates 2 times (40%).

What is ERIS.BO's current P/E ratio and EPS?

ERIS.BO trades at a trailing P/E of 30.87 on trailing EPS of 45.317620552434455 INR.

What do analysts rate ERIS.BO?

ERIS.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.